Autologous Transplantation Using Donor Leukocytes Loaded Ex Vivo with Oncolytic Myxoma Virus Can Eliminate Residual Multiple Myeloma

Autor: Villa, Nancy.Y., Rahman, Masmudur M., Mamola, Joseph., D’Isabella, Julia, Goras, Elizabeth, Kilbourne, Jacquelyn, Lowe, Kenneth, Daggett-Vondras, Juliane, Torres, Lino, Christie, John, Appel, Nicole, Cox, Anna L., Kim, Jae B., McFadden, Grant

Publikováno v: In Molecular Therapy - Oncolytics 25 September 2020 18:171-188

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Transplantation of autologous bone marrow pre-loaded ex vivo with oncolytic myxoma virus is efficacious against drug-resistant Vk*MYC mouse myeloma.

Autor: Villa NY; Biodesign Institute, Center for Immunotherapy, Vaccines and Virotherapy (CIVV), Arizona State University, Tempe, AZ 85281, USA.; Division of Hematology/Oncology, School of Medicine, Emory University, Atlanta, GA 32322, USA., Rahman MM; Biodesign Institute, Center for Immunotherapy, Vaccines and Virotherapy (CIVV), Arizona State University, Tempe, AZ 85281, USA., Mamola J; Biodesign Institute, Center for Immunotherapy, Vaccines and Virotherapy (CIVV), Arizona State University, Tempe, AZ 85281, USA., Sharik ME; Department of Medicine, Mayo Clinic, Scottsdale, AZ 85259, USA., de Matos AL; Biodesign Institute, Center for Immunotherapy, Vaccines and Virotherapy (CIVV), Arizona State University, Tempe, AZ 85281, USA., Kilbourne J; Biodesign Institute, Center for Immunotherapy, Vaccines and Virotherapy (CIVV), Arizona State University, Tempe, AZ 85281, USA., Lowe K; Biodesign Institute, Center for Immunotherapy, Vaccines and Virotherapy (CIVV), Arizona State University, Tempe, AZ 85281, USA., Daggett-Vondras J; Biodesign Institute, Center for Immunotherapy, Vaccines and Virotherapy (CIVV), Arizona State University, Tempe, AZ 85281, USA., D'Isabella J; Biodesign Institute, Center for Immunotherapy, Vaccines and Virotherapy (CIVV), Arizona State University, Tempe, AZ 85281, USA., Goras E; Biodesign Institute, Center for Immunotherapy, Vaccines and Virotherapy (CIVV), Arizona State University, Tempe, AZ 85281, USA., Chesi M; Department of Medicine, Mayo Clinic, Scottsdale, AZ 85259, USA., Bergsagel PL; Department of Medicine, Mayo Clinic, Scottsdale, AZ 85259, USA., McFadden G; Biodesign Institute, Center for Immunotherapy, Vaccines and Virotherapy (CIVV), Arizona State University, Tempe, AZ 85281, USA.

Publikováno v: Oncotarget [Oncotarget] 2022 Mar 03; Vol. 13, pp. 490-504. Date of Electronic Publication: 2022 Mar 03 (Print Publication: 2022).